IPX

IperionX Limited (IPX) Shareholder/Analyst Call Transcript

SOUTH BOSTON, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (NASDAQ: IPX, ASX: IPX) (IperionX) is pleased to invite shareholders and investors to a webinar on Tuesday, November 3, 2026 at 10:00 am Australian Eastern Daylight Time / Monday, November 2, 2026 at 18:00 pm U.S. Eastern Standard Time , where Founder and CEO, Taso Arima will provide a company update.

Advancing titanium beyond batch production: GenX™ has validated continuous HAMR™ processing, advancing beyond the batch model used in conventional Kroll titanium production. Major operating gains support the potential for lower unit costs, higher titanium throughput, and a modular capital-efficient expansion pathway Verified oxygen results: All valid product samples met the relevant oxygen benchmark: ASTM Grade 5 for angular powder and the more stringent Grade 23 specification for spherical titanium powder Six times throughput volume: Total throughput for the GenX™ furnace was six times the volume of the batch HAMR™ system, on a like-for-like run time basis Lower energy intensity: Power consumption reduced by more than 75% versus batch HAMR™ processing Substantially lower measured input use: More than 45% less magnesium and over 60% less hydrogen required per kilogram of titanium powder, relative to batch HAMR™ Further efficiency potential: Operational data highlights potential for far lower capex intensity (installed capital per ton of capacity) and the potential for significantly lower labor unit costs Next stage in Q4 2026: IperionX will continue to optimize the current GenX™ furnace; integrate the continuous furnace into a full titanium powder production line; and advance technoeconomic and engineering work for the first industrial-scale GenX™ production line SOUTH BOSTON, Va.

SOUTH BOSTON, Va., Aug. 31, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ: IPX, ASX: IPX) IperionX Limited announces that the U.S. Army has awarded Task Order 2 under the Small Business Innovation Research (SBIR) Phase III Indefinite Delivery, Indefinite Quantity (IDIQ) contract for Low-Cost, Domestic Titanium for Defense Applications.

LOS ANGELES--(BUSINESS WIRE)---- $IPX--IPX Investors Have Opportunity to Join IperionX Limited Fraud Investigation with SBS Law.

IperionX Limited (IPX) Shareholder/Analyst Call Transcript

Highlights  Proposed U.S. redomiciliation: IperionX intends to redomicile its ultimate parent company to Texas, subject to shareholder, court, regulatory and other customary approvals, to align the Company's legal and capital-markets structure with its integrated U.S. manufacturing, critical minerals and technology operations. Simplified Nasdaq structure: Subject to final structuring and exchange approvals, common stock in the new U.S. parent is expected to be listed directly on Nasdaq, replacing IperionX's existing ADS structure.

SOUTH BOSTON, Va., July 31, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (NASDAQ: IPX, ASX: IPX) (IperionX) is pleased to invite shareholders and investors to a webinar on Wednesday, August 5, 2026 at 8:00 am Australian Eastern Standard Time / Tuesday, August 4, 2026 at 18:00 pm U.S. Eastern Daylight Time , where Founder and CEO, Taso Arima will provide a company update.

SOUTH BOSTON, Va., July 30, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (Nasdaq: IPX | ASX: IPX) is pleased to present its quarterly report for the period ended June 30, 2026.

SOUTH BOSTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (“IperionX” or the “Company”) (Nasdaq:IPX; ASX:IPX) today announced the pricing of an underwritten public offering of 2,275,000 of its American Depositary Shares (“ADSs”), with each ADS representing 10 of its ordinary shares (“Public Offering”), at a price per ADS to the public of $21.98, for aggregate gross proceeds of approximately $50 million, before deducting underwriting discounts, commission and estimated offering expenses payable by the Company.